Phase Ib Study of Gedatolisib in Combination with Palbociclib and Endocrine Therapy (ET) in Women with Estrogen Receptor (ER) Positive (+) Metastatic Breast Cancer (MBC) (B2151009).
Journal of clinical oncology（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined